Tag: #immunitybio

Articles related to immunitybio

health

FDA Expands Use of Anktiva to Treat High-Grade Papillary Non‑Muscle Invasive Bladder Cancer

FDA expands Anktiva's approved use to adults with BCG‑unresponsive, high‑grade papillary-only non‑muscle invasive bladder cancer, providing a bladder‑sparing option.

#fda, #bladdercancer, #immunotherapy, #immunitybio